FDA calendar · November 2021 · built from SEC filings

PDUFA dates November 2021: FDA calendar and catalysts.

Updated Snapshot 20261116T222116ZBuilt

0 PDUFA dates fell in November 2021. The FDA calendar also recorded 11 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in November 2021

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

November 2021: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
November 4, 2021Byetta (exenatide synthetic)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
November 15, 2021Mvasi (bevacizumab-awwb)AMGNLabel expansion—ApprovedopenFDA Drugs@FDA
November 15, 2021Ruxience (rituximab-pvvr)PFELabel expansion—ApprovedopenFDA Drugs@FDA
November 17, 2021—ARMPFDA approval—ApprovedSEC Form 10-Q
November 17, 2021KEYTRUDA® (pembrolizumab)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
November 19, 2021Kanuma (sebelipase alfa)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
November 23, 2021TPOXX® (tecovirimat)SIGALabel expansion—ApprovedopenFDA Drugs@FDA
November 23, 2021Livtencity (maribavir)TAKFDA approval—ApprovedopenFDA Drugs@FDA
November 26, 2021Pedmark (sodium thiosulfate)FENCComplete Response Letter—CRL issuedFDA Complete Response Letters
November 29, 2021YCANTH (cantharidin)VRCANDA/BLA submissionmolluscumCompletedsec_424b
November 30, 2021Darzalex Faspro (daratumumab and hyaluronidase-fihj)JNJLabel expansion—ApprovedopenFDA Drugs@FDA

November 2021: dated readouts

No events in this view.

Questions

What PDUFA dates are in November 2021?

0 PDUFA dates fell in November 2021. The FDA calendar also recorded 11 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.